HSP70 EXPRESSION IS MODULATED BY ITS MASTER REGULATOR HSF1 VIA MAPKS AND PI3K/AKT/MTOR PATHWAYS IN CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Frezzato, F. [1 ,2 ]
Raggi, F. [1 ,2 ]
Accordi, B. [3 ]
Bresolin, S. [3 ]
Severin, F. [1 ,2 ]
Martini, V. [1 ,2 ]
Trimarco, V. [1 ,2 ]
Martinello, L. [1 ]
Visentin, A. [1 ,2 ]
Imbergamo, S. [1 ]
Scomazzon, E. [1 ]
Facco, M. [1 ,2 ]
Piazza, F. [1 ,2 ]
Basso, G. [3 ]
Semenzato, G. [1 ,2 ]
Trentin, L. [1 ,2 ]
机构：
[1] Univ Padua, Dept Med, Padua, Italy
[2] VIMM, Padua, Italy
[3] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1011
引用
收藏
页码：415 / 415
页数：1
相关论文
共 50 条
  • [1] HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia
    Frezzato, Federica
    Raggi, Flavia
    Martini, Veronica
    Severin, Filippo
    Trimarco, Valentina
    Visentin, Andrea
    Scomazzon, Edoardo
    Accordi, Benedetta
    Bresolin, Silvia
    Piazza, Francesco
    Facco, Monica
    Basso, Giuseppe
    Semenzato, Gianpietro
    Trentin, Livio
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (11) : 3089 - 3100
  • [2] HSP70/HSF1 AXIS IS INVOLVED IN IBRUTINIB-RESISTANCE MECHANISMS OF CHRONIC LYMPHOCYTIC LEUKEMIA CELLS
    Frezzato, F.
    Visentin, A.
    Bragagnolo, M.
    Severin, F.
    Pizzo, S.
    Lista, C.
    Facco, M.
    Piazza, F.
    Semenzato, G.
    Trentin, L.
    HAEMATOLOGICA, 2019, 104 : 101 - 101
  • [3] Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia
    Frezzato, Federica
    Visentin, Andrea
    Severin, Filippo
    Pizzo, Serena
    Ruggeri, Edoardo
    Mouawad, Nayla
    Martinello, Leonardo
    Pagnin, Elisa
    Trimarco, Valentina
    Tonini, Alessia
    Carraro, Samuela
    Pravato, Stefano
    Imbergamo, Silvia
    Manni, Sabrina
    Piazza, Francesco
    Brunati, Anna Maria
    Facco, Monica
    Trentin, Livio
    CANCERS, 2021, 13 (21)
  • [4] HSP70 AND HSF1 GO HAND IN HAND AND HAVE A ROLE IN THE SURVIVAL OF CHRONIC LYMPHOCYTIC LEUKEMIA NEOPLASTIC B CELLS
    Raggi, F.
    Federica, F.
    Martini, V.
    Severin, F.
    Trimarco, V.
    Martinello, L.
    Visentin, A.
    Scomazzon, E.
    Imbergamo, S.
    Facco, M.
    Piazza, F.
    Semenzato, G.
    Trentin, L.
    HAEMATOLOGICA, 2017, 102 : 710 - 710
  • [5] TARGETING THE INTERPLAY BETWEEN HSP70 (HEAT SHOCK PROTEIN OF 70KDA) AND HSF1 (HEAT SHOCK FACTOR 1) IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Frezzato, F.
    Raggi, F.
    Severin, F.
    Martini, V.
    Trimarco, V.
    Martinello, L.
    Visentin, A.
    Facco, M.
    Piazza, F.
    Semenzato, G.
    Trentin, L.
    HAEMATOLOGICA, 2016, 101 : S105 - S105
  • [6] Baicalin Targets HSP70/90 to Regulate PKR/PI3K/AKT/eNOS Signaling Pathways
    Hou, Yinzhu
    Liang, Zuqing
    Qi, Luyu
    Tang, Chao
    Liu, Xingkai
    Tang, Jilin
    Zhao, Yao
    Zhang, Yanyan
    Fang, Tiantian
    Luo, Qun
    Wang, Shijun
    Wang, Fuyi
    MOLECULES, 2022, 27 (04):
  • [7] 1-Methoxyerythrabyssin II Induces Autophagy in Leukemia Cells via PI3K/Akt/mTOR Pathways
    Fang, Bo
    Kim, Soeun
    Kim, Yebon
    Qiu, Yinda
    Lee, Chang-Min
    Lai, Yinshuang
    Liu, Zhiguo
    Wang, Kun
    Cho, Namki
    PLANTA MEDICA, 2023, 89 (13) : 1204 - 1214
  • [8] HSP70 inhibitor VER155008 suppresses pheochromocytoma cell and xenograft growth by inhibition of PI3K/AKT/mTOR and MEK/ERK pathways
    Xu, Feifei
    Lin, Dengqiang
    Jiang, Wen
    Meng, Li
    Xu, Yunze
    Wang, Chenghe
    Wang, Xiaojing
    He, Hongchao
    Xu, Danfeng
    Zhu, Yu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (07): : 2585 - 2594
  • [9] PI3K/Akt signaling pathway and Hsp70 activate in hippocampus of rats with chronic manganese sulfate exposure
    Cheng, Hong
    Xia, Bing
    Su, Cheng
    Chen, Kangcheng
    Chen, Xiang
    Chen, Pan
    Zou, Yunfeng
    Yang, Xiaobo
    JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2018, 50 : 332 - 338
  • [10] PI3K/AKT and mTOR/p70S6K1 Signaling Pathways in Human Cancer
    Jiang, Bing-Hua
    CURRENT CANCER DRUG TARGETS, 2013, 13 (03) : 233 - 233
12345